Stay updated with breaking news from Alkermes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
— Company Grants Teva a License to Market Generic VIVITROL Beginning in January 2027 — DUBLIN, Aug. 30, 2023 /PRNewswire/ -- Alkermes plc announced today that the company entered into...
U.S. stocks traded mixed, with the Dow Jones falling around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.
Shares of Alkermes PLC jumped 10% Wednesday after the Dublin-based biopharma company announced a settlement of patent litigation with Teva Pharmaceuticals...
(RTTNews) - Alkermes plc (ALKS) has entered into a settlement agreement with Teva Pharmaceuticals USA, Inc. to resolve the ongoing patent litigati...
Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including HP slipping on slower expected growth, Alkermes settling a…